Endovascular treatment strategies for cerebral vasospasm.

Stefan A. Mindea, Benson P. Yang, Bernard Bendok, Jeffrey W. Miller, H. Hunt Batjer

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Cerebral vasospasm is a significant cause of morbidity and mortality in patients who have sustained a subarachnoid hemorrhage from aneurysm rupture. Symptomatic cerebral vasospasm is also a strong predictor of poor clinical outcome and has thus drawn a great deal of interest from cerebrovascular surgeons. Although medical management is the cornerstone of treatment for this condition, endovascular intervention may be warranted for those in whom this treatment fails and in whom symptomatic vasospasm subsequently develops. The rapid advancements in endovascular techniques and pharmacological agents used to combat this pathological state continue to offer promise in broadening the available treatment armamentarium. In this article the authors discuss the rationale and basis for using the various endovascular options for the treatment of cerebral vasospasm, and they also discuss the limitations, complications, and efficacy of these treatment strategies in regard to neurological condition and outcome.

Original languageEnglish (US)
JournalNeurosurgical focus [electronic resource].
Volume21
Issue number3
StatePublished - 2006
Externally publishedYes

Fingerprint

Intracranial Vasospasm
Endovascular Procedures
Subarachnoid Hemorrhage
Therapeutics
Aneurysm
Rupture
Pharmacology
Morbidity
Mortality

Cite this

Mindea, S. A., Yang, B. P., Bendok, B., Miller, J. W., & Batjer, H. H. (2006). Endovascular treatment strategies for cerebral vasospasm. Neurosurgical focus [electronic resource]., 21(3).

Endovascular treatment strategies for cerebral vasospasm. / Mindea, Stefan A.; Yang, Benson P.; Bendok, Bernard; Miller, Jeffrey W.; Batjer, H. Hunt.

In: Neurosurgical focus [electronic resource]., Vol. 21, No. 3, 2006.

Research output: Contribution to journalArticle

Mindea, Stefan A. ; Yang, Benson P. ; Bendok, Bernard ; Miller, Jeffrey W. ; Batjer, H. Hunt. / Endovascular treatment strategies for cerebral vasospasm. In: Neurosurgical focus [electronic resource]. 2006 ; Vol. 21, No. 3.
@article{c915af47f4fa4817880e63c6ec1f4779,
title = "Endovascular treatment strategies for cerebral vasospasm.",
abstract = "Cerebral vasospasm is a significant cause of morbidity and mortality in patients who have sustained a subarachnoid hemorrhage from aneurysm rupture. Symptomatic cerebral vasospasm is also a strong predictor of poor clinical outcome and has thus drawn a great deal of interest from cerebrovascular surgeons. Although medical management is the cornerstone of treatment for this condition, endovascular intervention may be warranted for those in whom this treatment fails and in whom symptomatic vasospasm subsequently develops. The rapid advancements in endovascular techniques and pharmacological agents used to combat this pathological state continue to offer promise in broadening the available treatment armamentarium. In this article the authors discuss the rationale and basis for using the various endovascular options for the treatment of cerebral vasospasm, and they also discuss the limitations, complications, and efficacy of these treatment strategies in regard to neurological condition and outcome.",
author = "Mindea, {Stefan A.} and Yang, {Benson P.} and Bernard Bendok and Miller, {Jeffrey W.} and Batjer, {H. Hunt}",
year = "2006",
language = "English (US)",
volume = "21",
journal = "Neurosurgical Focus",
issn = "1092-0684",
publisher = "American Association of Neurological Surgeons",
number = "3",

}

TY - JOUR

T1 - Endovascular treatment strategies for cerebral vasospasm.

AU - Mindea, Stefan A.

AU - Yang, Benson P.

AU - Bendok, Bernard

AU - Miller, Jeffrey W.

AU - Batjer, H. Hunt

PY - 2006

Y1 - 2006

N2 - Cerebral vasospasm is a significant cause of morbidity and mortality in patients who have sustained a subarachnoid hemorrhage from aneurysm rupture. Symptomatic cerebral vasospasm is also a strong predictor of poor clinical outcome and has thus drawn a great deal of interest from cerebrovascular surgeons. Although medical management is the cornerstone of treatment for this condition, endovascular intervention may be warranted for those in whom this treatment fails and in whom symptomatic vasospasm subsequently develops. The rapid advancements in endovascular techniques and pharmacological agents used to combat this pathological state continue to offer promise in broadening the available treatment armamentarium. In this article the authors discuss the rationale and basis for using the various endovascular options for the treatment of cerebral vasospasm, and they also discuss the limitations, complications, and efficacy of these treatment strategies in regard to neurological condition and outcome.

AB - Cerebral vasospasm is a significant cause of morbidity and mortality in patients who have sustained a subarachnoid hemorrhage from aneurysm rupture. Symptomatic cerebral vasospasm is also a strong predictor of poor clinical outcome and has thus drawn a great deal of interest from cerebrovascular surgeons. Although medical management is the cornerstone of treatment for this condition, endovascular intervention may be warranted for those in whom this treatment fails and in whom symptomatic vasospasm subsequently develops. The rapid advancements in endovascular techniques and pharmacological agents used to combat this pathological state continue to offer promise in broadening the available treatment armamentarium. In this article the authors discuss the rationale and basis for using the various endovascular options for the treatment of cerebral vasospasm, and they also discuss the limitations, complications, and efficacy of these treatment strategies in regard to neurological condition and outcome.

UR - http://www.scopus.com/inward/record.url?scp=33750587743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750587743&partnerID=8YFLogxK

M3 - Article

C2 - 17029337

AN - SCOPUS:33750587743

VL - 21

JO - Neurosurgical Focus

JF - Neurosurgical Focus

SN - 1092-0684

IS - 3

ER -